Patents/Assignees

Curevac SE

55 patents in portfolio

US12208165utility2025
Dry Powder Composition Comprising Long-chain RNA
0 cites
US12201680utility2025
Nucleic Acid Comprising or Coding for a Histone Stem-loop and a Poly(a) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Pathogenic Antigen
0 cites
US12201682utility2025
Henipavirus Vaccine
0 cites
US12194089utility2025
Coronavirus Vaccine
0 cites
US12178863utility2024
Combination of Vaccination and OX40 Agonists
0 cites
US12168050utility2024
Compositions Comprising a Norovirus Nucleic Acid and Methods of Use Thereof
0 cites
US12161711utility2024
Lassa Virus Vaccine
0 cites
US12138348utility2024
Dry Powder Composition Comprising Long-chain RNA
0 cites
US12139513utility2024
Respiratory Syncytial Virus (RSV) Vaccine
0 cites
US12109275utility2024
Nucleic Acid Comprising or Coding for a Histone Stem-loop and a Poly(a) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Protein
0 cites
US12097253utility2024
RSV RNA Molecules and Compositions for Vaccination
0 cites
US12083190utility2024
Rabies Vaccine
0 cites
US12048738utility2024
Composition for Treating Prostate Cancer (pca)
0 cites
US12036277utility2024
Vaccination with Mrna-coded Antigens
0 cites
US11975064utility2024
Vaccination with Mrna-coded Antigens
0 cites
US11964011utility2024
Coronavirus Vaccine
0 cites
US11964012utility2024
Coronavirus Vaccine
0 cites
US11965000utility2024
Respiratory Syncytial Virus (RSV) Vaccine
0 cites
US11920174utility2024
RNA Analysis by Total Hydrolysis and Quantification of Released Nucleosides
0 cites
US11883486utility2024
Coronavirus Vaccine
0 cites

← PreviousPage 2 of 3Next →